# Toshinari Yamasaki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/toshinari-yamasaki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,524 |
| Field | Renal cell carcinoma treatment |
| h-index | 28 |
| i10-index | 56 |
| Last Known Institution | Kobe City Medical Center General Hospital |
| OpenAlex ID | https://openalex.org/A5009447665 |
| Works | 228 |

## Researcher papers

- [BAP1 loss defines a new class of renal cell carcinoma](https://scholariq.org/papers/bap1-loss-defines-a-new-class-of-renal-cell-carcinoma/)
- [Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism](https://scholariq.org/papers/prevalence-of-cardiovascular-disease-and-its-risk-factors-in-primary/)
- [A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma](https://scholariq.org/papers/a-validated-tumorgraft-model-reveals-activity-of-dovitinib-against-renal-cell/)
- [Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab](https://scholariq.org/papers/incidence-features-and-prognosis-of-immune-related-adverse-events-involving-the/)
- [Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma](https://scholariq.org/papers/interplay-between-pvhl-and-mtorc1-pathways-in-clear-cell-renal-cell-carcinoma/)
- [Exposure–Toxicity Relationship of Sorafenib in Japanese Patients with Renal Cell Carcinoma and Hepatocellular Carcinoma](https://scholariq.org/papers/exposure-toxicity-relationship-of-sorafenib-in-japanese-patients-with-renal-cell/)
- [Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism](https://scholariq.org/papers/obesity-as-a-key-factor-underlying-idiopathic-hyperaldosteronism/)
- [Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer](https://scholariq.org/papers/clinical-utility-of-androgen-receptor-gene-aberrations-in-circulating-cell-free/)
- [Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer](https://scholariq.org/papers/decreased-expression-of-lysophosphatidylcholine-16-0-oh-in-high-resolution/)
- [Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies](https://scholariq.org/papers/systematic-chemical-screening-identifies-disulfiram-as-a-repurposed-drug-that/)
- [Laparoscopic Forceps with Force Feedback](https://scholariq.org/papers/laparoscopic-forceps-with-force-feedback/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)

## Researcher university

- [Kobe City Medical Center General Hospital](https://scholariq.org/institutions/kobe-city-medical-center-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.